Navigation Links
Most Read Pharmaceutical and Health News - March '13
Date:4/23/2013

AUSTIN, Texas, April 23, 2013 /PRNewswire/ -- dailyRx News Network announced today the most popular health topics viewed and shared during March 2013. dailyRx News publishes and syndicates consumer-centric health information across YouTube, mobile apps, various news aggregators, as well as through a national network of healthcare providers' social media channels.

"As the digital age evolves, a growing number of adults are using their smartphones and tablets to research health news and information," said Donald W. Hackett , CEO and Publisher of dailyRx News. "It is important that on-the-go eHealth consumers have access to a trusted digital health news resource at their fingertips," Hackett added.

According to Pew Research Center's Project for Excellence in Journalism, digital news consumption was up to 50% in 2012, increasing from 44% in 2010. In addition, a study by InSite Consulting found that 42% of people turn to TV as their primary and initial device in breaking news situations, with 66% then using the Internet to further investigate stories.

Health conditions generating notable viewer engagement on dailyRx.com last month included:

March's most-viewed medications included:

Trending health news throughout dailyRx social media included:

About dailyRx News Network
dailyRx News Network is an emerging leader in publishing health news for consumers and patients alike. dailyRx publishes, aggregates, and syndicates doctor-reviewed news covering a wide range of health conditions, medications, over-the-counter products, and nutraceutical compounds. dailyRx's original content is written in positive, unbiased, easy-to-understand language and reviewed for accuracy by doctors, pharmacists, and therapists. dailyRx, Inc. is a Patient Conversation Media company.


'/>"/>
SOURCE dailyRx News Network
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. European Nuclear Medicine / Radiopharmaceuticals Market - Global Trends & Forecasts to 2017
2. Pharmaceutical Companies On Defense As Post-ACA Implementation Continues
3. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
4. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
5. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
6. Biopharmaceutical Managed Care Strength Closely Intertwined with Marketplace Success
7. ADial Pharmaceuticals Announces Agreement With FDA For Phase III Trial Of AD04 For Alcohol Use Disorder In Patients Of Targeted Genotypes
8. Comparison of Biopharmaceutical Industry Between China and India 2013
9. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
10. Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
11. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Ore. , May 3, 2016   ... medical technology, today announced Food and Drug Administration ... resynchronization defibrillator that provides heart failure patients with ... Iperia devices also have remote monitoring with daily ... adapts the heart rate in response to physiological ...
(Date:5/3/2016)... YORK , May 3, 2016 ... (MRI) Market Size, Share, Development, Growth and Demand Forecast ... Open), by Field Strength (High Field, Very High Field, ... Application (Brain, Head and Neck, Spine, Musculoskeletal, Vascular, Breast, ... the global magnetic resonance imaging (MRI) market was valued ...
(Date:5/3/2016)... 3, 2016 Norgine ... sie einen entscheidenden Meilenstein durch diese Veröffentlichung ... zum Handeln, um Patientenresultate  bei Verdauungs- und ... Fortschritten im Verständnis der Hepatischen Enzephalopathie bei ... für Hepatische Enzephalopathie in der Öffentlichkeit zu ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... May 03, 2016 , ... Sandbox, one ... Ferrazano to serve in the newly created position of executive vice president, chief ... creative efforts in the Chicago and LA offices. He reports to Nancy Finigan, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Excessive panting in the car ... anxiety. "Pet owners often think anxiety only manifests itself as trembling or ‘tail ... ways, and there’s things that be done about it,” says Dr. Jim Lowe, technical ...
(Date:5/3/2016)... Boston, MA (PRWEB) , ... May 03, 2016 , ... ... where clinicians can rehearse tough medical situations or practice tricky or rare procedures in ... Longwood Medical Area, the SIM Center is also available to inventors and “hackers” to ...
(Date:5/3/2016)... ... 03, 2016 , ... Ogawa World USA introduced the first of its kind ... exclusive Smart Application. The Smart 3D combines the best in technological advancement, design, and ... profile and specialized massage program, each user has a tailored experience unparalleled by any ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... of innovative information technology (IT) solutions and digital consulting services to the federal ... Technology Services (EITS) Indefinite Delivery / Indefinite Quantity (ID/IQ) contract in support of ...
Breaking Medicine News(10 mins):